QGEN

Qiagen N.V. Press Releases

$23.2
*  
0.09
0.39%
Get QGEN Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading QGEN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
QIAGEN to Distribute altona Diagnostic''s RealStar® Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use
12/4/2014 4:00:00 PM - PR Newswire


QIAGEN to Distribute altona Diagnostic's RealStar® Ebolavirus RT-PCR Kit 1.0, Recently Authorized by the FDA for Emergency Use
12/4/2014 4:00:00 PM - PR Newswire
▼-2.40 % Price Change since this news event. The Volume Ratio is 1.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN Signs Ninth Master Collaboration Agreement for Companion Diagnostics
11/11/2014 4:00:00 PM - PR Newswire
▼-2.52 % Price Change since this news event. The Volume Ratio is 1.07.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN Reports Results for Third Quarter and First Nine Months of 2014
10/29/2014 4:00:00 PM - PR Newswire
▼-1.11 % Price Change since this news event. The Volume Ratio is 0.95.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics
10/28/2014 4:00:00 PM - PR Newswire
▼-1.07 % Price Change since this news event. The Volume Ratio is 1.35.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN Applauds Inclusion of Screening and Treatment for Latent Infection in WHO''s Post-2015 Global Strategy to End Tuberculosis
10/28/2014 1:35:00 PM - PR Newswire
▼-0.43 % Price Change since this news event. The Volume Ratio is 2.5.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN Demonstrates Expanded Bioinformatics Workflows at ASHG; Strong Market Adoption as Researchers Analyze Genomic Data on More Than a Quarter-Million Samples in Secure Private Cloud
10/17/2014 4:00:00 PM - PR Newswire
▲5.84 % Price Change since this news event. The Volume Ratio is 0.64.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Genomics England Names QIAGEN Bioinformatics One of the UK100K Project Assessment Winners
10/14/2014 11:39:00 AM - Business Wire
▲7.36 % Price Change since this news event. The Volume Ratio is 0.73.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


QIAGEN N.V. to Report Third Quarter 2014 Results and Hold Webcast
10/10/2014 11:30:00 AM - PR Newswire
▲5.65 % Price Change since this news event. The Volume Ratio is 1.02.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day